Search research articles
Contact Us
Filters
Showing results (371-380 of 400) with videos related to
Page
of 40
Sort By:
Scientific Reports
|
July 15, 2018
Sustainable Syntheses of (-)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
Christopher J Smedley, Paul A Stanley, Mohannad E Qazzaz, et al.
Cancer Care Research Online
|
April 8, 2024
A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources with Patients' Symptom Burden
Janet H Van Cleave, Catherine Concert, Maria Kamberi, et al.
Inflammatory Bowel Diseases
|
October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Journal of Autoimmunity
|
June 8, 2019
The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity
Liangfang Yao, Lei Zhou, Yang Xuan, et al.
Nature Communications
|
August 12, 2021
Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation
Xiaohong Tan, Lu Tong, Lin Li, et al.
Inflammatory Bowel Diseases
|
March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Nature Communications
|
April 16, 2021
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
Simon Bo Jensen, Sara Thodberg, Shaheena Parween, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2019
Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics Combination
Ran Nir-Paz, Daniel Gelman, Ayman Khouri, et al.
Nature Communications
|
June 15, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium
Kyong T Fam, Pavan Kumar Chodisetti, Zifei Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant <i>Enterococcus faecium</i>
Kyong T Fam, Pavan Kumar Chodisetti, Zifei Wang, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 400) with videos related to
Sort By:
Page
of 40
Scientific Reports
|
July 15, 2018
Sustainable Syntheses of (-)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
Christopher J Smedley, Paul A Stanley, Mohannad E Qazzaz, et al.
Cancer Care Research Online
|
April 8, 2024
A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources with Patients' Symptom Burden
Janet H Van Cleave, Catherine Concert, Maria Kamberi, et al.
Inflammatory Bowel Diseases
|
October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Journal of Autoimmunity
|
June 8, 2019
The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity
Liangfang Yao, Lei Zhou, Yang Xuan, et al.
Nature Communications
|
August 12, 2021
Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation
Xiaohong Tan, Lu Tong, Lin Li, et al.
Inflammatory Bowel Diseases
|
March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Nature Communications
|
April 16, 2021
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
Simon Bo Jensen, Sara Thodberg, Shaheena Parween, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2019
Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics Combination
Ran Nir-Paz, Daniel Gelman, Ayman Khouri, et al.
Nature Communications
|
June 15, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium
Kyong T Fam, Pavan Kumar Chodisetti, Zifei Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant <i>Enterococcus faecium</i>
Kyong T Fam, Pavan Kumar Chodisetti, Zifei Wang, et al.
Page
of 40